Persistence of SARS-CoV-2 RNA in lung tissue after mild COVID-19

Laurens J. Ceulemans; Mona Khan; Seung‐Jun Yoo; Bolek Zapiec; Laura Van Gerven; Jan Van Slambrouck; Arno Vanstapel; Dirk Van Raemdonck; Robin Vos; Els Wauters; Joost Wauters; Peter Carmeliet; Peter Mombaerts

doi:10.1016/s2213-2600(21)00240-x

Related publications

Article2023

Epigenetic Fingerprint of the SARS-CoV-2 Infection in the Lung of Lethal COVID-19

Aleix Noguera‐Castells, Jerónimo Parra, Verónica Dávalos, Carlos A. García‐Prieto, Yoana Veselinova, Belén Perez‐Mies, Tamara Caniego-Casas, José Palacios, Xavier Saenz-Sardà, Elisabet Englund, Eva Musulén, Manel Esteller

Article2021

Survival and Incidence of COVID-19 After SARS-CoV-2 Vaccination in a Series of 2391 Cancer Patients

Pierre-Étienne Heudel, Bertrand Favier, Marie-Laure Solodky, Souad Assaad, Natacha Chaumard, Olivier Trédan, Thomas Bachelot, I. Ray-Coquard, Bruno Russias, Marie‐Line Fournier, Bénédicte Mastroïanni, Virginie Avrillon, Anne‐Sophie Michallet, Philippe Zrounba, Sylvie Chabaud, David Pérol, Jean Yves Blay

Article2022

Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients

Pierre-Étienne Heudel, Bertrand Favier, Marie-Laure Solodky, Souad Assaad, Natacha Chaumard, Olivier Trédan, Thomas Bachelot, I. L. Ray-Coquard, Bruno Russias, Marie‐Line Fournier, Bénédicte Mastroïanni, Virginie Avrillon, Anne‐Sophie Michallet, Philippe Zrounba, Sylvie Chabaud, David Pérol, Jean Yves Blay

Article2021

Perspectives for antivirals to limit SARS-CoV-2 infection (COVID-19)

De Clercq Erik

Article2023

Two years of SARS-CoV-2 pandemic and COVID-19 in Lombardy, Italy

Pier Mannuccio Mannucci, Alessia Antonella Galbussera, Barbara D’Avanzo, Mauro Tettamanti, Giuseppe Remuzzi, Ida Fortino, Olivia Leoni, Sergio Harari, Alessandro Nobili